Hôpital le corbusier
- Address
- 2 rue Robert Ploton, 42704 Firminy, France
Hôpital le Corbusier - Vascular Medicine Research
Hôpital le Corbusier is actively engaged in cardiovascular and thrombotic disease research, with particular emphasis on optimizing treatment strategies for patients with complex coagulation management needs. The center focuses on developing evidence-based therapeutic approaches for patients requiring dual antithrombotic therapy.
- Acute venous thromboembolism management and treatment optimization
- Anticoagulation therapy in patients with concurrent cardiovascular conditions
- Bleeding risk assessment in complex antithrombotic regimens
The research conducted at Hôpital le Corbusier addresses critical clinical challenges in patients with acute VTE who are already receiving antiplatelet therapy for secondary arterial prevention. The center's investigations aim to define the safest and most effective antithrombotic strategies, balancing the prevention of thromboembolic events against the risk of clinically relevant bleeding complications in this high-risk patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hôpital le corbusier
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE | Centre Hospitalier Universitaire De Saint Etienne | Phase III | Recruiting | Aug 2023 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acenocoumarol | 1 | Unknown | 2023-08-12 | 2023-08-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.